Peptide Profile

NAD+

Nicotinamide Adenine Dinucleotide

Research Only10 sourcesShop NAD+

Overview

Composition

Vital coenzyme present in every cell, functioning as a key mediator in energy metabolism, mitochondrial function, DNA repair, sirtuin activation, and redox reactions

Mechanism of Action

Supports cellular energy production (via ATP synthesis), combats oxidative stress, and influences pathways linked to aging, inflammation, and metabolic health

Primary Effects

NAD+ biology is central to mitochondrial energy production, DNA repair, and stress-response signaling, but direct NAD+ interventions have less outcome evidence than precursor research.

Discovery & Background

First identified in 1906 during yeast fermentation studies by Arthur Harden and William Young

Research progressed from fermentation biochemistry to redox biology, then to modern work on sirtuins, PARP enzymes, mitochondrial aging, and NAD+ precursor strategies.

Not FDA-approved for any indication; precursors have stronger data; direct NAD+ lacks broad regulatory approval for therapeutic use

Research Overview

Evidence stems from preclinical models (animals, cells) showing NAD+ restoration improves mitochondrial function, insulin sensitivity, neuroprotection, and lifespan extension

01
Human studies are limited—mostly on precursors (NR/NMN) demonstrating safe NAD+ elevation, metabolic benefits, and tolerability
02
Direct NAD+ clinical evidence is less mature than nicotinamide riboside and nicotinamide mononucleotide research
03
Experts note poor cellular penetration (NAD+ is large/unstable, often excreted or degraded)
04
No large-scale RCTs confirm long-term efficacy for routine aging or disease treatment
05
Anecdotal reports praise energy/cognition gains, but placebo effects and variability are concerns

Not FDA-approved for any indication; precursors have stronger data

Safety Considerations

Monitoring

Energy levels
Cognitive function
Metabolic markers
Overall vitality
Medication and cancer-history context when interpreting redox biology claims

Side Effects

Common

Warmth or flushing has been reported
Nausea
Transient fatigue
Flushing or warmth

Unknown

Long-term safety (e.g., cancer risk unknowns) remains understudied

Contraindications

Not approved by major regulatory bodies (e.g., FDA) for therapeutic use
Experts often prefer precursors for bioavailability and evidence
Limited strong human trial support for most claims

Educational Notice

It is not approved by major regulatory bodies for therapeutic use, and long-term safety (e.g., cancer risk unknowns) remains understudied. Always consult a qualified healthcare professional before considering NAD+ for personal application.

References